SleepinessIPACPNCT05464342
Integral Physiological Adaptations to Carbohydrate Periodization
A study testing Evening LGI Carbohydrate Consumption Group, Evening HGI Carbohydrate Consumption and Evening NO-CHO Carbohydrate Consumption in people with Sleepiness and Fatigue, run by University of Thessaly at 2 sites in 2 countries.
Trial summary
The purpose of this study is to examine the effect of long-term carbohydrate periodization protocols on sleep architecture, sleep quality, daytime sleepiness, physical performance, body composition, gut microbiome, and miRNA in healthy trained individuals. Read more about this study
- Who is it for?
- Ages 18 to 50 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Sleepiness, Fatigue, Feeding Patterns
- What is being tested?
- Evening LGI Carbohydrate Consumption Group, Evening HGI Carbohydrate Consumption and Evening NO-CHO Carbohydrate Consumption
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 5 Jul 2022to 31 May 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Both sexes, Age between 18 and 50 yrs old, Regularly participating in sports activities.
Who cannot join
- Any kind of history of major diseases or medication, Excessive amounts of alcohol and caffeine consumption
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
Greece1 site
Lifestlye Medicine Laboratory, TEFAA, University of Thessaly
Trikala, Thessaly, 42100
About this study
The purpose of this study is to examine the effect of long-term carbohydrate periodization protocols on sleep architecture, sleep quality, daytime sleepiness, physical performance, body composition, gut microbiome, and miRNA in healthy trained individuals.
Read the detailed description
Athletic populations have been particularly susceptible to sleep inadequacies, experience several sleep issues, and fall below the age-specific sleep recommendations. However, it is well demonstrated that exercise does not impair sleep by itself, and furthermore, acute post-exercise nutrition could elevate the exercise-induced sleep-optimizing effect, with further benefits for the next physical performance. In line with these findings, in a metanalysis of clinical trials, it was shown that pre-bed carbohydrate availability resulted in significant alterations in sleep architecture. It is of utmost importance to highlight that throughout this metanalysis, it was revealed that no long-term nutrition intervention for sleep optimization has been studied yet. These data raise the question of whether a long-term carbohydrate periodization protocol could optimize sleep and alter gut function in a way that athletic performance will be also enhanced. This would allow elucidating further potential interrelations and biological pathways underlying these adaptations.
- Conditions
- Sleepiness, Fatigue, Feeding Patterns, Daytime Sleepiness, Excessive
- Being tested
- Evening LGI Carbohydrate Consumption Group, Evening HGI Carbohydrate Consumption, Evening NO-CHO Carbohydrate Consumption
- Keywords
- sleep, Carbohydrate periodization, Dietary Intervention, Sports Nutrition, Chrononutrition, Chronobiology, Gut Microbiome, miRNA
- Medical subject headings
- Sleepiness, Fatigue, Feeding Behavior, Disorders of Excessive Somnolence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Evening LGI Carbohydrate Consumption GroupBehavioural
Participants will receive in the evening food with low glycemic index
Evening HGI Carbohydrate ConsumptionBehavioural
Participants will receive in the evening food with high glycemic index
Evening NO-CHO Carbohydrate ConsumptionBehavioural
Participants will receive in the evening a meal with no carbohydrates at all.
| Study group | Role | What they receive |
|---|---|---|
| Evening LGI Carbohydrate Consumption | Experimental | Dietary Intervention: Consumption of Low Glyceamic Index (LGI) carbohydrates intake post-workout/evening. Receives: Behavioral: Evening LGI Carbohydrate Consumption Group |
| Evening HGI Carbohydrate Consumption | Experimental | Dietary Intervention: Consumption of High Glyceamic Index (HGI) carbohydrates intake post-workout/evening. Receives: Behavioral: Evening HGI Carbohydrate Consumption |
| Evening NO-CHO Carbohydrate Consumption | Experimental | Dietary Intervention: No consumption of carbohydrates intake post-workout/evening. Receives: Behavioral: Evening NO-CHO Carbohydrate Consumption |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sleep Efficiency
Changes sleep efficiency assessed by the gold-standard method of polysomnography. Sleep efficiency is the percentage of time spent asleep while in bed. It is calculated by dividing the amount of time spent asleep (in minutes) by the total amount of time in bed (in minutes). A normal sleep efficiency is considered to be 85% or higher.
Measured: Assessed at 0-month (pre) and at 1-month (post)
Quality of Sleep Score
Changes in Quality of Sleep will be assessed by the Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as the global score) indicating worse sleep quality.
Measured: Assessed at 0-month (pre) and at 1-month (post)
Daytime Sleepiness
Changes in Daytime sleepiness will be assessed by Epworth Sleepiness Scale (ESS). The Epworth Sleepiness Scale (ESS) measures the general level of daytime sleepiness. It is a subjective scale that asks the respondent to rate his or her propensity to doze or fall asleep during 8 common daily activities to determine the level of daytime sleepiness. The score varies between 0-24 with 0-5 Lower Normal Daytime Sleepiness, 6-10 Higher Normal Daytime Sleepiness, 11-12 Mild Excessive Daytime Sleepiness, 13-15 Moderate Excessive Daytime Sleepiness, 16-24 Severe Excessive Daytime Sleepiness.
Measured: Assessed at 0-month (pre) and at 1-month (post)
Secondary outcomes (4)
Body Composition
Changes in Body composition. The changes in body composition will be assessed by the skinfold measurements and BIA
Measured: Assessed at 0-month (pre) and at 1-month (post)
Exercise Performance
Changes in Exercise Performance will be assessed by a VO2max test. A VO2 max test is a maximal exercise test performed on a treadmill or bike while connected to a machine capable of analyzing your expired air. Your test provides data on how much oxygen you use as you exercise and determines the maximal oxygen you can consume during exercise.
Measured: Assessed at 0-month (pre) and at 1-month (post)
Gut Microbiome
Changes in Gut Microbiome. Participants' gut microbiome will be studied by analyzing stool samples DNA will be extracted, and the presence of selected gut bacterial populations will be examined qualitatively and quantitatively using specific primers and quantitative Real-Time PCR.
Measured: Assessed at 0-month (pre) and at 1-month (post)
miRNA levels
Changes in miRNA levels. miRNA levels that are associated with hypertrophy or cardiovascular function will be analyzed by blood sample collection at baseline and at one month.
Measured: Assessed at 0-month (pre) and at 1-month (post)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jul 2022
- Study start5 Jul 2022
- Primary completion1 Apr 2023
- Study completion31 May 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for SleepinessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a randomized controlled trial. The study is composed of three groups, differentiating on evening carbohydrate quantity and quality (glycaemic index) intake. The trial period will last for 1 month for all groups. Intervention includes lifestyle changes, targeting exercise, and diet. The design is parallel.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Thessaly
- Sponsor type
- University, hospital or other
- Collaborators
- University of Nicosia, University of Cyprus
- Responsible party
- Principal investigator, Giorgos K. Sakkas, University of Thessaly
- Investigators
- Georgios Sakkas, PhD, Study chair, University of Thessaly
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05464342
- Sponsor's protocol ID
- EEBK/EΠ/2018/10
- Acronym
- IPACP
- Status last verified
- Jun 2023
- First submitted
- 4 Jul 2022
- Last updated
- 5 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Vlahoyiannis A, Andreou E, Aphamis G, Felekkis K, Pieri M, Sakkas GK, Giannaki CD. Evaluating the evening carbohydrate dilemma: the effect of within-the-day carbohydrate periodization on body composition and physical fitness. Eur J Nutr. 2024 Nov 25;64(1):23. doi: 10.1007/s00394-024-03540-6.
PubMed 39585451Vlahoyiannis A, Andreou E, Bargiotas P, Aphamis G, Sakkas GK, Giannaki CD. The effect of chrono-nutritional manipulation of carbohydrate intake on sleep macrostructure: A randomized controlled trial. Clin Nutr. 2024 Mar;43(3):858-868. doi: 10.1016/j.clnu.2024.02.016. Epub 2024 Feb 15.
PubMed 38367595
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Integral Physiological Adaptations to Carbohydrate Periodization
- ClinicalTrials.gov ID
- NCT05464342
- Acronym / sponsor ID
- IPACP / EEBK/EΠ/2018/10
- Conditions
- Sleepiness, Fatigue, Feeding Patterns, Daytime Sleepiness, Excessive
- Keywords
- sleep, Carbohydrate periodization, Dietary Intervention, Sports Nutrition, Chrononutrition, Chronobiology, Gut Microbiome, miRNA
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- University of ThessalyUniversity, hospital or other
- Collaborators
- University of Nicosia, University of Cyprus
- Study start
- 5 Jul 2022 (actual)
- Primary completion
- 1 Apr 2023 (actual)
- Study completion
- 31 May 2023 (actual)
- First posted
- 19 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to examine the effect of long-term carbohydrate periodization protocols on sleep architecture, sleep quality, daytime sleepiness, physical performance, body composition, gut microbiome, and miRNA in healthy trained individuals.
Detailed description
Athletic populations have been particularly susceptible to sleep inadequacies, experience several sleep issues, and fall below the age-specific sleep recommendations. However, it is well demonstrated that exercise does not impair sleep by itself, and furthermore, acute post-exercise nutrition could elevate the exercise-induced sleep-optimizing effect, with further benefits for the next physical performance. In line with these findings, in a metanalysis of clinical trials, it was shown that pre-bed carbohydrate availability resulted in significant alterations in sleep architecture. It is of utmost importance to highlight that throughout this metanalysis, it was revealed that no long-term nutrition intervention for sleep optimization has been studied yet. These data raise the question of whether a long-term carbohydrate periodization protocol could optimize sleep and alter gut function in a way that athletic performance will be also enhanced. This would allow elucidating further potential interrelations and biological pathways underlying these adaptations.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
- Model description
- This is a randomized controlled trial. The study is composed of three groups, differentiating on evening carbohydrate quantity and quality (glycaemic index) intake. The trial period will last for 1 month for all groups. Intervention includes lifestyle changes, targeting exercise, and diet. The design is parallel.
| Arm | Type | Receives |
|---|---|---|
| Evening LGI Carbohydrate Consumption | Experimental | Behavioral: Evening LGI Carbohydrate Consumption GroupDietary Intervention: Consumption of Low Glyceamic Index (LGI) carbohydrates intake post-workout/evening. |
| Evening HGI Carbohydrate Consumption | Experimental | Behavioral: Evening HGI Carbohydrate ConsumptionDietary Intervention: Consumption of High Glyceamic Index (HGI) carbohydrates intake post-workout/evening. |
| Evening NO-CHO Carbohydrate Consumption | Experimental | Behavioral: Evening NO-CHO Carbohydrate ConsumptionDietary Intervention: No consumption of carbohydrates intake post-workout/evening. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Both sexes, Age between 18 and 50 yrs old, Regularly participating in sports activities.
Key exclusion criteria (1 listed)
- Any kind of history of major diseases or medication, Excessive amounts of alcohol and caffeine consumption
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Evening LGI Carbohydrate Consumption GroupParticipants will receive in the evening food with low glycemic index | Behavioural | Evening LGI Carbohydrate Consumption |
| Evening HGI Carbohydrate ConsumptionParticipants will receive in the evening food with high glycemic index | Behavioural | Evening HGI Carbohydrate Consumption |
| Evening NO-CHO Carbohydrate ConsumptionParticipants will receive in the evening a meal with no carbohydrates at all. | Behavioural | Evening NO-CHO Carbohydrate Consumption |
Primary outcome
Sleep Efficiency
Time frame: Assessed at 0-month (pre) and at 1-month (post)
Changes sleep efficiency assessed by the gold-standard method of polysomnography. Sleep efficiency is the percentage of time spent asleep while in bed. It is calculated by dividing the amount of time spent asleep (in minutes) by the total amount of time in bed (in minutes). A normal sleep efficiency is considered to be 85% or higher.
Quality of Sleep Score
Time frame: Assessed at 0-month (pre) and at 1-month (post)
Changes in Quality of Sleep will be assessed by the Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score. The sleep component scores are summed to yield a total score ranging from 0 to 21 with the higher total score (referred to as the global score) indicating worse sleep quality.
Daytime Sleepiness
Time frame: Assessed at 0-month (pre) and at 1-month (post)
Changes in Daytime sleepiness will be assessed by Epworth Sleepiness Scale (ESS). The Epworth Sleepiness Scale (ESS) measures the general level of daytime sleepiness. It is a subjective scale that asks the respondent to rate his or her propensity to doze or fall asleep during 8 common daily activities to determine the level of daytime sleepiness. The score varies between 0-24 with 0-5 Lower Normal Daytime Sleepiness, 6-10 Higher Normal Daytime Sleepiness, 11-12 Mild Excessive Daytime Sleepiness, 13-15 Moderate Excessive Daytime Sleepiness, 16-24 Severe Excessive Daytime Sleepiness.
4 secondary outcomes
Body Composition
Time frame: Assessed at 0-month (pre) and at 1-month (post)
Exercise Performance
Time frame: Assessed at 0-month (pre) and at 1-month (post)
Gut Microbiome
Time frame: Assessed at 0-month (pre) and at 1-month (post)
miRNA levels
Time frame: Assessed at 0-month (pre) and at 1-month (post)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2023.
- Derived from this study: PubMed 39585451Vlahoyiannis A, Andreou E, Aphamis G, Felekkis K, Pieri M, Sakkas GK, Giannaki CD. Evaluating the evening carbohydrate dilemma: the effect of within-the-day carbohydrate periodization on body composition and physical fitness. Eur J Nutr. 2024 Nov 25;64(1):23. doi: 10.1007/s00394-024-03540-6.
- Derived from this study: PubMed 38367595Vlahoyiannis A, Andreou E, Bargiotas P, Aphamis G, Sakkas GK, Giannaki CD. The effect of chrono-nutritional manipulation of carbohydrate intake on sleep macrostructure: A randomized controlled trial. Clin Nutr. 2024 Mar;43(3):858-868. doi: 10.1016/j.clnu.2024.02.016. Epub 2024 Feb 15.
- Individual participant dataSharing planned: No
Related trials for Sleepiness
Not yet recruitingPhase 3
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
Apnea, Sleep Disorders
Not yet recruiting
Predicting Declines in Attention and Memory During a Prolonged Mental Task
Mental Fatigue, Cognitive Performance
Not yet recruitingPhase 4
Testing Healthy Participants for Drowsiness After Single Dosing of Two Different Doses of Muscle Relaxer
Healthy Participants
RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
RecruitingPhase 2/3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Georgios Sakkas, PhD study chair
University of Thessaly
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Evening LGI Carbohydrate Consumption Group, Evening HGI Carbohydrate Consumption and Evening NO-CHO Carbohydrate Consumption in people with Sleepiness and Fatigue, run by University of Thessaly at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Cyprus, Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sleep Efficiency (time frame: Assessed at 0-month (pre) and at 1-month (post)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05464342, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2023.